Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Clinical trial NCT06203821 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06203821
- Sponsor
- Aram Hezel
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-05-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.